OMERS ADMINISTRATION Corp Boosts Position in HCA Healthcare, Inc. (NYSE:HCA)

OMERS ADMINISTRATION Corp grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,067 shares of the company’s stock after acquiring an additional 421 shares during the period. OMERS ADMINISTRATION Corp’s holdings in HCA Healthcare were worth $3,922,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Whipplewood Advisors LLC bought a new position in HCA Healthcare in the fourth quarter worth approximately $31,000. Tidemark LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter worth $36,000. Activest Wealth Management raised its holdings in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares in the last quarter. Pinnacle Bancorp Inc. boosted its holdings in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares in the last quarter. Finally, Eastern Bank bought a new position in shares of HCA Healthcare during the 4th quarter worth approximately $62,000. Institutional investors own 62.73% of the company’s stock.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 1.4%

HCA stock opened at $368.33 on Wednesday. The business has a fifty day simple moving average of $337.71 and a 200-day simple moving average of $328.08. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company has a market cap of $88.61 billion, a price-to-earnings ratio of 16.77, a PEG ratio of 1.10 and a beta of 1.46.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts’ consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter last year, the firm posted $5.36 EPS. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.78%. The ex-dividend date is Monday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 12.81%.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. StockNews.com upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Monday, April 28th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Baird R W cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Bank of America reduced their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Finally, Robert W. Baird reissued a “neutral” rating and issued a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $381.13.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.